396 related articles for article (PubMed ID: 35142071)
21. Stimulus-Responsive Nanomedicines for Disease Diagnosis and Treatment.
Liu G; Lovell JF; Zhang L; Zhang Y
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887466
[TBL] [Abstract][Full Text] [Related]
22. Microenvironment-Responsive Magnetic Nanocomposites Based on Silver Nanoparticles/Gentamicin for Enhanced Biofilm Disruption by Magnetic Field.
Wang X; Wu J; Li P; Wang L; Zhou J; Zhang G; Li X; Hu B; Xing X
ACS Appl Mater Interfaces; 2018 Oct; 10(41):34905-34915. PubMed ID: 30240195
[TBL] [Abstract][Full Text] [Related]
23. Emerging nanoparticle designs against bacterial infections.
Zhou Z; Kai M; Wang S; Wang D; Peng Y; Yu Y; Gao W; Zhang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1881. PubMed ID: 36828801
[TBL] [Abstract][Full Text] [Related]
24. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine.
Song Y; Ding Y; Dong CM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1742. PubMed ID: 34310063
[TBL] [Abstract][Full Text] [Related]
25. Endogenous stimuli-responsive drug delivery nanoplatforms for kidney disease therapy.
Fang H; Xu S; Wang Y; Yang H; Su D
Colloids Surf B Biointerfaces; 2023 Dec; 232():113598. PubMed ID: 37866237
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle approaches against bacterial infections.
Gao W; Thamphiwatana S; Angsantikul P; Zhang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
[TBL] [Abstract][Full Text] [Related]
27. Infection microenvironment-related antibacterial nanotherapeutic strategies.
Wang Z; Liu X; Duan Y; Huang Y
Biomaterials; 2022 Jan; 280():121249. PubMed ID: 34801252
[TBL] [Abstract][Full Text] [Related]
28. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
29. Stimuli-sensitive drug delivery systems for site-specific antibiotic release.
Nazir F; Tabish TA; Tariq F; Iftikhar S; Wasim R; Shahnaz G
Drug Discov Today; 2022 Jun; 27(6):1698-1705. PubMed ID: 35219858
[TBL] [Abstract][Full Text] [Related]
30. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
Wang S; Gao Y; Jin Q; Ji J
Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
[TBL] [Abstract][Full Text] [Related]
31. Trends in Photothermal Nanostructures for Antimicrobial Applications.
Dediu V; Ghitman J; Gradisteanu Pircalabioru G; Chan KH; Iliescu FS; Iliescu C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298326
[TBL] [Abstract][Full Text] [Related]
32. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
33. Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.
Sun Y; Davis E
Nanomaterials (Basel); 2021 Mar; 11(3):. PubMed ID: 33809633
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the redox-responsive drug delivery nanoplatforms: A chemical structure and physical property perspective.
Mollazadeh S; Mackiewicz M; Yazdimamaghani M
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111536. PubMed ID: 33255089
[TBL] [Abstract][Full Text] [Related]
35. Photo-triggered polymer nanomedicines: From molecular mechanisms to therapeutic applications.
Beauté L; McClenaghan N; Lecommandoux S
Adv Drug Deliv Rev; 2019 Jan; 138():148-166. PubMed ID: 30553952
[TBL] [Abstract][Full Text] [Related]
36. Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges.
Li B; Liao Y; Su X; Chen S; Wang X; Shen B; Song H; Yue P
J Nanobiotechnology; 2023 Sep; 21(1):325. PubMed ID: 37684605
[TBL] [Abstract][Full Text] [Related]
37. Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives.
Arroyo-Urea EM; Lázaro-Díez M; Garmendia J; Herranz F; González-Paredes A
Nanomedicine (Lond); 2024 Feb; 19(4):325-343. PubMed ID: 38270350
[TBL] [Abstract][Full Text] [Related]
38. The Smart Drug Delivery System and Its Clinical Potential.
Liu D; Yang F; Xiong F; Gu N
Theranostics; 2016; 6(9):1306-23. PubMed ID: 27375781
[TBL] [Abstract][Full Text] [Related]
39. Stimuli-Actuated Turn-On Theranostic Nanoplatforms for Imaging-Guided Antibacterial Treatment.
Yang S; Song Y; Dong H; Hu Y; Jiang J; Chang S; Shao J; Yang D
Small; 2023 Dec; 19(52):e2304127. PubMed ID: 37649207
[TBL] [Abstract][Full Text] [Related]
40. Nanostructures for pH-sensitive Drug Delivery and Magnetic Resonance Contrast Enhancement Systems.
Sun X; Zhang G; Wu Z
Curr Med Chem; 2018; 25(25):3036-3057. PubMed ID: 28393692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
